Project Details
Description
The successfully completion of this project will provide strong preclinical supports for UBCMT19 and its nano-enabled formula as a new class of immunotherapeutics for treating malignant urethral bladder cancer and cancer stem cells.
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/21 → 7/31/22 |
Keywords
- Urothelial bladder cancer
- cancer stem cells
- tumor immune microenvironment
- M2 tumor-associated macrophages
- exosomes
- immunotherapy
- nano-enabled drug
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.